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Abstract
Objective: How fertility patients utilise assisted reproductive services can depend on how easy it is to access
such services locally. Little data exist to document the extent of economic outflow that accompanies cross-
border patient travel specifically for medical procedures that cannot be obtained in country.
Methods: In this investigation, data from Luxembourg’s social security agency were used to audit medical
reimbursement payments for IVF within and outside the Grand Duchy of Luxembourg between 1998 and
2007. This study interval offered an opportunity to track IVF expenditures before and after IVF was made
freely available within the Grand Duchy.
Results: Reimbursement authorizations to IVF providers outside Luxembourg remained stable or slightly
elevated until 2005, two years after Luxembourg opened its first IVF centre. Once established in Luxembourg,
annual utilisation of the domestic IVF service generally trended upwards (217 cycles in 2003 vs. 569 in 2008).
Meanwhile, payments to foreign IVF clinics declined steadily after 2005 reflecting a diminishing number of
Luxembourg patients seeking cross-border IVF treatment.
Conclusion: These data represent the most comprehensive register of cross-border reproductive visits in
Europe. Since Luxembourg fully reimburses its citizens for health-related expenses irrespective of where the
medical service is obtained, the current investigation renders the “out of pocket” effect of IVF fees irrelevant
and characterise consumption of elective medical treatments as a function of service site. Further studies are
needed to determine if these findings will generalise to other geographic regions.
 
Introduction
Procedures such as in-vitro fertilization (IVF) and intra-
cytoplasmic sperm injection (ICSI) allow as many as one
third of women who would otherwise remain childless to
conceive. Although more than half of all recorded cycles
of in vitro fertilization (IVF) worldwide have been under-
taken in Europe [1], there remains considerable diversity
in European public funding strategies for treating infertil-
ity [2]. Of equal importance, there is a lack of consensus
on how countries should use limited public resources to
treat infertility [3]. Whereas gynaecologists in the more
populated European countries tend to routinely treat
patients with fertility problems, practitioners in smaller
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ncountries often refer their Assisted Reproductive Tech-
nologies (ART) patients to neighboring jurisdictions, par-
ticularly when specialist facilities are not available locally
or where tighter fiscal policies govern assisted conception
[4–7].
The Grand Duchy of Luxembourg, with its present popu-
lation of slightly less than a half million inhabitants, did
not immediately embrace the advanced reproductive tech-
nologies when these first became available. As a result,
patients requiring medically assisted reproductive techni-
ques had no option other than to seek care outside of their
home country. This de facto system of recourse to foreign
competencies for reproductive care was useful for a small
nation, especially as patient expenses for treatments
obtained in neighbouring Belgium, France and Germany
(99.8% of all foreign care authorizations) were reimbursed
at full cost by Luxembourg’s healthcare system.
Despite the advantages of a centralized, single-payer sys-
tem in Luxembourg, the medical establishment recog-
nized that recourse to foreign medical care, often requiring
numerous follow-up appointments, added considerable
stress to couples who were already under pressure because
they were unable to achieve a healthy pregnancy. Accord-
ingly, plans were eventually undertaken to offer ART by
way of a specialized clinic located in the maternity build-
ing at the Centre Hospitalier de Luxembourg. Today, in
terms of professional staff, this fertility unit comprises
eight doctors, one embryologist, four technicians, and two
midwives. Although no specific laws govern the practice
of ART in Luxembourg, this clinic abides by European
standards of medical practice and the French Bioethics
Laws of 1994 [8]. Since its launch in 2000, the Luxem-
bourg Fertility Clinic has performed 2,737 cycles of ART
for couples who otherwise would have required treatment
in a foreign country (Table 1). In addition, this facility has
collected outcomes data on the demographics and effec-
tiveness of every ART procedure it has administered
(Table 2). These data are submitted to the Ministry of
Health and Social Security and studied to determine the
need for ongoing quality improvements to methodologies
and practices. Because medical records are computerized,
population-based analyses can be conducted.
The information system of the Luxembourg social secur-
ity agency can retrospectively audit medical care con-
sumption and demographic variables of patients receiving
reimbursement payments for healthcare within and out-
side the Grand Duchy of Luxembourg. Such data represent
the most comprehensive register of cross-border repro-
ductive visits by any group of individuals in Europe.
Methods
Medical care consumption and demographic data were
collected by the Administration of the Medical Control of
the Social Security System (CMSS) of Luxembourg for
all foreign care authorizations since 1998. Services
obtained outside the Grand Duchy included magnetic res-
onance imaging, coronary bypass grafting, treatments of
malignant tumours, and infertility. Our study included all
patients who received treatments for infertility outside the
Grand Duchy since data started being recorded in 1998,
and all patients who received ART services inside the
Grand Duchy after these services became available locally
in 2003. All data were tabulated in an anonymous and non-
identifiable manner, in accordance with standards prescri-
bed by our institutional review panel. The database com-
prised 181,231 patient encounters, analysed with SAS
Version 9.2. A total of 22,803 care authorizations were
excluded from analysis based upon truncated data
obtained in 2008, refused claims, or pending care author-
izations. A total of 158,428 care authorizations (for 48,514
patients) were included for study.
Results
Before 2003, any patient in Luxembourg who needed spe-
cialist ART consultation did so outside of Luxembourg.
Table 1.
Annual assisted fertility service payments associated with Luxembourg fertility patients designated to medical pro-
viders outside the Grand Duchy of Luxembourg, 1998–2007.
Year
  Patients (n)
 
Foreign ART disbursement authorizations
(n)
 
1998 491 1054
1999 449 961
2000 421 815
2001 526 1015
2002 480 932
2003a 493 977
2004 562 1041
2005 517 928
2006 304 532
2007
  278
  450
 
a
In 2003, assisted reproductive treatments became locally available for the first time within Luxembourg
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which the first specialized ART centre opened within
Luxembourg. This unique circumstance provided an
opportunity to examine before- and after-patterns of ART
care within a defined population where cost factors could
be closely monitored. National reimbursement authoriza-
tions assessed during the study interval revealed that
recourse to foreign ART services outside of Luxembourg
remained stable or slightly elevated until 2005 (Table 1).
Subsequently, utilisation of foreign care providers
declined and, as expected, the country’s domestic uptake
of ART services increased (Table 2). In terms of medical
care utilization, considering the elective nature of fertility
treatments, the 8,705 foreign care authorizations (see
Table 1) surpasses the 10yr aggregate total of 2,451
authorizations for radiotherapy and the 883 authorizations
for coronary artery bypass procedures by 355% and 986%,
respectively [9].
Service utilisation patterns for patients receiving care at
the only provider of IVF in Luxembourg are shown in
Table 2. A 44% increase in pregnancy rate was noted from
2005 to 2006 (32 vs. 46 clinical pregnancies), and a 70%
increase was observed from 2006 to 2007 (46 vs. 78 clin-
ical pregnancies).
Discussion
These data highlight women’s acceptance of IVF treat-
ment in Luxembourg, and indicate how proximity and
convenience can impact the provision of the assisted
reproductive technologies. Substantial public funding was
required to establish fertility services in Luxembourg, and
these findings regarding public utilisation of more locally
available ART services is noteworthy. The literature on
reliance on foreign competencies for specialist care in
reproductive medicine is limited, and we are unaware of
government datasets describing the number of individuals
leaving a given jurisdiction specifically due to lack of
nearby services, and how that may change once they
become locally available. To study this, the Luxembourg
Social Security System was used to capture all reimbursed
foreign care authorizations. Stated another way, since
results of internal governmental analyses are not typically
placed in the public domain, the present investigation
offers an unusual opportunity to characterise consumption
of fertility services as a function of service site. In terms
of access to care, the number of IVF cycles undertaken by
Luxembourg patients in 2004 was comparable to other
European reference groups (see Table 3). However,
because neither live birth rates per cycle of treatment nor
overall multiple birth rate could be reliably calculated, it
was impossible to make international comparisons beyond
access to care.
Our study was limited by a relatively short sampling time
and a specific geographic focus. Patients obtaining IVF
treatment outside of Luxembourg might have selected a
foreign clinic for personal reasons, irrespective of the
service being provided locally. In addition, travel to a for-
eign location for IVF could have some non-reimbursed
associated expenses that could add to the stress of the
infertility experience. Obtaining IVF at a domestic unit
likely was accompanied by reduced anxiety, but this was
not directly measured in this investigation. It should be
noted that our study identified a small proportion (< 5%)
Table 2.
Summary of reproductive outcomes following IVF in Luxembourg, 2003–2008.
Year
  Initiated cycles (n)
  Clinical pregnancy/ET (%)
 
2003 217 30.0
2004 259 36.4
2005 246 36.8
2006 379 36.4
2007 537 32.0
2008
  569
  42.7
 
Notes: Data describe treatment activity at the only IVF provider in the Grand Duchy of Luxembourg, Centre Hospitalier de Luxembourg. ET = embryo transfer.
Table 3.
Overview of IVF activity in selected E.U. jurisdictions (2004).
Country
  Reporting IVF Clinics (n)
  Number of IVF Cycles
  Total Population (n)
 
ART cycles/1,000 Popula-
tion
 
Iceland 1 234 293,577 0.80
Luxembourg 1 259 454,960 0.57
Belgium 18 13,794 10,445,852 1.32
United Kingdom 74 18,375 59,846,000 0.31
France 100 55,217 60,963,000 0.91
Germany
  120
  38,824
  82,500,849
  0.47
 
Note: Non-Luxembourg data derived from ESHRE reports (Hum Reprod 2008;23:756–71).
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from locations outside the Grand Duchy.
At the same time, our analysis is strengthened by its inclu-
sion of a statistically homogeneous population sample
(>95% from Luxembourg) who underwent IVF proce-
dures during a defined period. Although very few coun-
tries reimburse patients for 100% of IVF cost, none to our
knowledge besides Luxembourg are able to stratify
healthcare disbursements by specific medical procedures
obtained abroad. Finally, the advantage of entering the
world fertility stage late in the game, as was the case in
Luxembourg, could only provide the local physicians with
the benefits of an extensive literature.
Future directions and conclusions
The demographics of childlessness and patterns of medi-
cal care utilization have changed rapidly since assisted
reproduction first appeared as a viable option in England
in 1978. In Luxembourg, the numbers of women who
received authorization to undertake ART at a foreign
clinic declined markedly after 2005. As other specialist
care facilities continue to expand within Luxembourg, it
is reasonable to suppose that further changes will occur in
the need to travel abroad for medical care. Increasing
availability of domestic specialist care will clearly affect
the return on the sizable recent investments in clinical
facilities, as well as decrease the external efflux of public
funds to foreign clinics. Whereas Luxembourg has one of
the largest per capita to GDP ratios of healthcare invest-
ment in the world [10], this figure is undoubtedly influ-
enced by recent capital expenditures to improve services
that will be amortized with time. The observed increase in
domestic utilization in the present specialty highlights the
likely human capital and wider economic returns on these
investments.
One of the additional advantages of conducting public
health research in Luxembourg is that data tend to be
comprehensive, population-based and used to form the
basis of a national comparison. Over the next few years,
the Government of Luxembourg plans to deploy a new
Birth-related Health-monitoring System (SUSANA) to
monitor mothers’ and babies’ health outcomes over time,
and implement preventative measures based on the results
of specific interventions. Interlocking results from the
SUSANA dataset with the research methodology descri-
bed here (focusing specifically on ART services) repre-
sents the focus of future studies.
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